Core summary of product characteristics for human tetanus immunoglobulin for intramuscular use

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/BPWG/3730/02
Published27/07/2005
Effective from01/02/2006
KeywordsHuman tetanus immunoglobulin, post exposure prophylaxis, clinically manifest tetanus
DescriptionThis document describes the information to be included in the summary of product characteristics for human tetanus immunoglobulin for intramascular use.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more